Evaluation Epidermolysis Bullosa: Advances in Research and Treatment Evaluation HMP Education would appreciate your feedback on the quality and impact of this activity.Please answer the following questions, some of which include a 5-point Likert scale (5 = strongly agree/excellent/great deal; 1 = strongly disagree/poor/very little). Did this activity meet your educational needs? Yes No Did this activity increase your competence? Yes No Do you feel like there were any new data presented during this activity? Yes - please explain: No Did you learn anything new? Yes, please specify: No Did you gain confidence in your ability to act on the new information? Yes - please explain: No Did this activity include opportunities to learn as a part of a healthcare team? Yes - please explain: No Please answer the following question using a 5-point likert scale (5 = a great deal, 3 = a modest amount, 1 = nothing at all). How much did you learn as a result of this session? 5 4 3 2 1 Please rate the following components related to this activity using a 5-point likert scale (5 = excellent, 3 = good, 1 = poor). Content 5 4 3 2 1 Relevance to your practice 5 4 3 2 1 Educational format 5 4 3 2 1 Overall 5 4 3 2 1 Please rate the faculty on their knowledge, expertise, and teaching ability (5= excellent, 3 = good, 1 = poor). Mercedes E. Gonzalez, MD 5 4 3 2 1 Fernanda Schmidt, MD 5 4 3 2 1 To what extent were the following learning objectives addressed by this activity (5 = entirely, 3 = moderately, 1 = not at all)? Explain the epidemiology, pathogenesis, classification, and clinical features of Epidermolysis bullosa 5 4 3 2 1 Recognize the burden of the disease on persons living with EB, their family and caregivers 5 4 3 2 1 Implement appropriate diagnostic tests to confirm the diagnosis of epidermolysis bullosa and guide treatment decisions 5 4 3 2 1 Apply the principles of wound care and infection prevention specific to epidermolysis bullosa to minimize skin trauma and reduce the risk of secondary infections 5 4 3 2 1 Employ a multidisciplinary, cooperative, and iterative approach to the management of persons with EB 5 4 3 2 1 Examine unmet needs in the management of patients with EB and research of new and emerging treatment therapies 5 4 3 2 1 The information presented in this activity was free of commercial bias. Agree Disagree Do you intend to make any additional changes to your practice as a result of information gained from this activity? Please be specific. Yes, please describe: No Which of the following barriers do you perceive in your efforts to implement practice changes and/or optimize patient care? Select all that apply. No barriers Cost Lack of opportunity/patients Lack of administrative support Insurance/reimbursement issues Lack of consensus or professional guidelines Lack of time to assess/counsel patients Patient compliance issues Not applicable to my practice Other: How might future activities help you address those barriers? 255 characters max Previous
